Institution statistics

SANOFI-AVENTIS - France 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:300-400
Total Number of Projects:200-300
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 64
As coordinator: 0
As participant: 64
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 36.525.742 0 4
2019 0 214.067.873 0 15
2018 0 141.754.731 0 9
2017 0 116.469.714 0 12
2016 0 100.977.934 0 10
2015 0 30.153.461 0 3
2014 0 587.134 0 1
2013 0 8.197.401 528.552 2
2012 0 14.978.147 136.203 3
2011 0 15.625.805 0 2
2010 0 30.456.183 0 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA13
PFIZER LIMITED13
ELI LILLY AND COMPANY LIMITED11
JANSSEN PHARMACEUTICA NV10
KATHOLIEKE UNIVERSITEIT LEUVEN9
ASTRAZENECA7
F HOFFMANNLA ROCHE7
KING'S COLLEGE LONDON7
BAYER6
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT6
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE6
STICHTING KATHOLIEKE UNIVERSITEIT6
TAKEDA DEVELOPMENT CENTRE EUROPE6
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
LEIDS UNIVERSITAIR MEDISCH CENTRUM5
MERCK SHARP & DOHME CORP5
NOVO NORDISK5
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE5
UCB BIOPHARMA5
UNIVERSITA VITASALUTE SAN RAFFAELE5
UNIVERSITY OF DUNDEE5
ABBVIE INC4
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE4
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE4
JDRF INTERNATIONAL4
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITY OF NEWCASTLE UPON TYNE4
UNIVERSITY OF TAMPERE4
ACADEMIC MEDICAL CENTRE AMSTERDAM3
ACADEMISCH ZIEKENHUIS GRONINGEN3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
AUSTRIAN RESEARCH CENTERS SIEBERDORF3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS3
COVANCE LABORATORIES3
DRESDEN UNIVERSITY OF TECHNOLOGY3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA3
KAROLINSKA INSTITUTE3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
LUNDS UNIVERSITET3
MEDIZINISCHE UNIVERSITAET WIEN3
MEDTRONIC INTERNATIONAL TRADING SARL3
REGION HOVEDSTADEN3
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU3
SIB INSTITUT SUISSE DE BIOINFORMATIQUE3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
TAKEDA PHARMACEUTICALS INTERNATIONAL3
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA3
THE UNIVERSITY OF SHEFFIELD3
UNIVERSITAET ZUERICH3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITE DU LUXEMBOURG3
UNIVERSITY OF COPENHAGEN3
UPPSALA UNIVERSITET3
ALLERGAN LIMITED2
BRISTOLMYERS SQUIBB COMPANY CORP2
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL2
CENTRE DE RECHERCHE PUBLIC DE LA SANTE2
CENTRE DE REGULACIO GENOMICA2
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY2
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER2
CENTRO DE INVESTIGACION BIOMEDICA EN RED2
DREEM2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING2
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
EUROPEAN PATIENTS' FORUM2
FORUM DES PATIENTS EUROPEENS2
FUJIFILM CELLULAR DYNAMICS INC2
GOETEBORGS UNIVERSITET2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
ISTITUTO SUPERIORE DI SANITA2
IXSCIENT LIMITED2
MCROBERTS BV2
MEDIZINISCHE HOCHSCHULE HANNOVER2
MEDIZINISCHE UNIVERSITAT GRAZ2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
ORION OYJ2
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
REGION STOCKHOLM2
SERVICIO ANDALUZ DE SALUD2
STICHTING MLC FOUNDATION2
STICHTING VUMC2
SYDDANSK UNIVERSITET2
TEAM IT RESEARCH SL2
THE EUROPEAN MEDICINES AGENCY2
THE HYVE BV2
THE LEONA M AND HARRY B HELMSLEY CHARITABLE TRUST2
THE QUEEN'S UNIVERSITY OF BELFAST2
Constancy:

Total number of partners:636

Partner loyalty:
Frequent Partner: (> 2 projects): 281
Rare Partner: 355

Frequent / Rare Partner Ratio: 0.79

Diversity:

Subjects:
Subject:No:
Diversity index:0
Categories:
Category:No:

Project overview:

Start dateProjectacronymrolefundingpartners
2020-10-01H2O Health Outcomes Observatory H2Oparticipant10.476.68723
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2020-05-01Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA INNODIA HARVESTparticipant5.999.05540
2020-01-01Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies ImmUniverseparticipant15.500.00026
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52346
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95336
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99831
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89734
2019-04-01Biomarkers in Atopic Dermatitis and Psoriasis BIOMAPparticipant10.500.00032
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-03-01Efficiently Networking European Neurodegeneration Research NEURONETparticipant1.199.12510
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMparticipant6.700.00021
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99827
2019-01-01Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain IM2PACTparticipant9.000.00027
2019-01-01Vaccines and Infectious Diseases in the Ageing PopuLation VITALparticipant5.499.88224
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-05-01Hypoglycaemia - REdefining SOLutions for better liVEs Hypo-RESOLVEparticipant13.450.05723
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00048
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00035
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93134
2017-11-01Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections COMBACTE-CDIparticipant2.312.30514
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-09-01Rheuma Tolerance for Cure RTCureparticipant6.000.00020
2017-07-01Development of Robust and Innovative Vaccine Effectiveness DRIVEparticipant8.999.81315
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-02-01Cardio Ultraefficient nanoParticles for Inhalation of Drug prOducts CUPIDOparticipant6.094.78113
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106 IB4SD-TRISTANparticipant12.000.00021
2017-01-01Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine MultipleMSparticipant14.721.45322
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-04-01Assessing risk and progression of prediabetes and type 2 diabetes to enable disease modification - Sofia ref.: 115881 RHAPSODYparticipant8.130.00027
2016-03-01Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 VAC2VACparticipant7.850.00023
2016-03-01PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910 PERISCOPEparticipant21.000.00024
2016-03-01Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH). MAST4HEALTHparticipant2.124.00013
2016-01-01Imaging the Force of Cancer FORCEparticipant5.812.63116
2016-01-01ISOTOPIC LABELING FOR DRUG INNOVATION ISOTOPICSparticipant3.948.84413
2016-01-01European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates EHVAparticipant22.188.52243

overview shows latest 50 from 64 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:
  • SANOFI AVENTIS
  • SANOFI PASTEUR
  • SANOFIAVENTIS
  • SANOFIAVENTIS DEUTSCHLAND
  • SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT
  • SANOFIS AVENTIS DEUTSCHLAND

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum